Showing results (671-680 of 2,865) with videos related to

Sort By:
Pageof 287
JACC. Cardiovascular Interventions|June 9, 2026
Comparison of Leaflet Modification Techniques for TAV-in-TAV: Insights From Bench TestingArif A Khokhar, Alessandro Beneduce, Francesco Tartaglia, et al.
JACC. Cardiovascular Interventions|June 9, 2026
Leaflet Splitting to Prevent TAVR-Induced Coronary Obstruction in Stented vs Stentless Surgical Bioprosthetic ValvesInes Richter, Ahmed Abdelhafez, Jonas Lanz, et al.
JACC. Cardiovascular Interventions|March 6, 2017
Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions: A Subanalysis of the International, Multicenter GHOST-EU RegistrySalvatore Geraci, Hiroyoshi Kawamoto, Giuseppe Caramanno, et al.
JACC. Cardiovascular Interventions|February 25, 2012
Long-term comparison of everolimus- and sirolimus-eluting stents in patients with acute coronary syndromesBindu Kalesan, Giulio G Stefanini, Lorenz Räber, et al.
JACC. Cardiovascular Interventions|January 6, 2018
1-Year Clinical Outcomes in Women After Transcatheter Aortic Valve Replacement: Results From the First WIN-TAVI RegistryAlaide Chieffo, Anna Sonia Petronio, Julinda Mehilli, et al.
JACC. Cardiovascular Interventions|January 6, 2018
Sex-Specific Outcomes of Transcatheter Aortic Valve Replacement With the SAPIEN 3 Valve: Insights From the PARTNER II S3 High-Risk and Intermediate-Risk CohortsMolly Szerlip, Sarah Gualano, Elizabeth Holper, et al.
JACC. Cardiovascular Interventions|February 9, 2019
Sex Disparities in Cardiovascular Device Evaluations: Strategies for Recruitment and Retention of Female Patients in Clinical Device TrialsM Imran Ghare, Jaya Chandrasekhar, Roxana Mehran, et al.
JACC. Cardiovascular Interventions|February 24, 2018
Appropriateness and Outcomes of Percutaneous Coronary Intervention at Top-Ranked and Nonranked Hospitals in the United StatesDevraj Sukul, Deepak L Bhatt, Milan Seth, et al.
JACC. Cardiovascular Interventions|March 11, 2022
The Impact of Intravascular Ultrasound on Femoropopliteal Artery Endovascular Interventions: A Randomized Controlled TrialRichard B Allan, Phillip J Puckridge, J Ian Spark, et al.
JACC. Cardiovascular Interventions|January 25, 2014
The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplastyDierk Scheinert, Stephan Duda, Thomas Zeller, et al.
Pageof 287